| Trial ID: | L0021 |
| Source ID: | NCT01285362
|
| Associated Drug: |
Fish Oil
|
| Title: |
Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Fish Oil Supplementation|Drug: Placebo Supplementation
|
| Outcome Measures: |
Prevalence of normalized liver enzyme levels|Prevalence of insulin resistance attenuated
|
| Sponsor/Collaborators: |
Columbia University|GlaxoSmithKline
|
| Gender: |
All
|
| Age: |
12 Years to 18 Years ?? (Child, Adult)
|
| Phases: |
Not applicable
|
| Enrollment: |
8
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
March 2013
|
| Completion Date: |
September 2014
|
| Results First Posted: |
--
|
| Last Update Posted: |
March 9, 2015
|
| Locations: |
Irving Clinical Research Center (GCRC) at Columbia University Medical Center, New York, New York, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT01285362
|
